Search Results
26 Mohamed Tarik Bakri New horizons in Management of Patients with CKD in T2D – Role of Finerenon
Jennifer Green, EASD 2022: Finerenone & Empagliflozin in patients with CKD and T2D: CONFIDENCE Study
Finerenone, a non-steroidal MRA
Finerenone in CKD - Prof. Mohamed Kamal Nassar - 2nd Nephro-ESMA 2022
FIGARO-DKD Trial Results
Dr. Mathew John - Newer molecules in Diabetic kidney disease - Finrenone
Discovery of Finerenone | Dr Lars Bärfacker (Bayer) | Society of Chemical Industry YCP/FCG Webinar
Нефропротекция у пациентов с диабетом. Ингибиторы НГЛТ и антагонисты рецепторов минералокортикоидов
Insights from the FIGARO-DKD and FIDELIO-DKD trials - English Language - Dr. Gawad
Nephrologie (II) - Prof. M. Säemann, PD M. Antlanger, PD A. Kronbichler, Prof. M. Girndt
Cardiovascular events with finerenone in kidney disease and type 2 diabetes - Dr. Luis Miguel Ruiz
Peer Learning
